Preferred Name | Dideoxyadenosine | |
Synonyms |
|
|
Definitions |
A prodrug form of didanosine, a nucleoside reverse transcriptase inhibitor analog of adenosine. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C429 |
|
CAS_Registry |
4097-22-7 |
|
Chemical_Formula |
C10H13N5O2 |
|
code |
C429 |
|
Contributing_Source |
FDA |
|
definition |
A prodrug form of didanosine, a nucleoside reverse transcriptase inhibitor analog of adenosine. |
|
FDA_UNII_Code |
4Q86AH641A |
|
in_subset | ||
label |
Dideoxyadenosine |
|
Legacy Concept Name |
Dideoxyadenosine |
|
NCI_Drug_Dictionary_ID |
40799 |
|
NSC Number |
98700 |
|
PDQ_Closed_Trial_Search_ID |
40799 |
|
PDQ_Open_Trial_Search_ID |
40799 |
|
Preferred_Name |
Dideoxyadenosine |
|
prefixIRI |
NCIT:C429 |
|
prefLabel |
Dideoxyadenosine |
|
Semantic_Type |
Pharmacologic Substance Nucleic Acid, Nucleoside, or Nucleotide |
|
UMLS_CUI |
C0012131 |
|
subClassOf |
Create mapping